This GIS is to inform local departments of social services and the Human Resources Administration (HRA) of changes to the fee-for-service pharmacy benefit for full benefit Medicare/Medicaid dual eligibles.
Effective October 1, 2011, the Medicaid program will no longer pay for Medicare Part D drugs in the following drug classes when billed for full benefit Medicare/Medicaid dual eligibles: atypical antipsychotics antidepressants antiretrovirals used in the treatment of HIV/AIDS antirejection drugs used for tissue and organ transplants.
|